Overview of the Molecular Modalities and Signaling Pathways Intersecting with β-Amyloid and Tau Protein in Alzheimer’s Disease
Alzheimer’s disease (AD) is one of the major causes of dementia and its incidence represents approximately 60–70% of all dementia cases worldwide. Many theories have been proposed to describe the pathological events in AD, including deterioration in cognitive function, accumulation of β-amyloid, and...
Main Authors: | Ahmed M. Elshazly, Melanie M. Sinanian, Diaaeldin M. Elimam, Sherin Zakaria |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Neuroglia |
Subjects: | |
Online Access: | https://www.mdpi.com/2571-6980/4/3/14 |
Similar Items
-
Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer’s disease
by: Ana-Caroline Raulin, et al.
Published: (2024-02-01) -
Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
by: Niklas Mattsson‐Carlgren, et al.
Published: (2021-06-01) -
Interactions between apolipoprotein E, sex, and amyloid-beta on cerebrospinal fluid p-tau levels in the European prevention of Alzheimer's dementia longitudinal cohort study (EPAD LCS)
by: Tyler S. Saunders, et al.
Published: (2022-09-01) -
Mitochondrial Calcium Deregulation in the Mechanism of Beta-Amyloid and Tau Pathology
by: Noemi Esteras, et al.
Published: (2020-09-01) -
Apolipoprotein E ε4 and ε3 alleles associate with cerebrospinal fluid tau and cognition in the presence of amyloid-𝜷 in mild cognitive impairment but not in Alzheimer’s disease
by: Feng Xing, et al.
Published: (2021-06-01)